PREDICTING KIDNEY FUNCTION AND END-STAGE KIDNEY DISEASE IN ANCA-ASSOCIATED VASCULITIS USING ANCA, C-REACTIVE PROTEIN AND C3

被引：0
|
作者：
Domingues, Patricia [1 ]
Inacio, Antonio Silva [1 ]
Piedade, Ana [1 ]
Verde, Ricardo [2 ]
Duarte, Jesuina [2 ]
Santos, Patricia Valerio [1 ]
Soto, Karina [1 ]
Cunha, Liliana [1 ]
机构：
[1] Ctr Hosp Setubal, Nephrol, Setubal, Portugal
[2] Ctr Hosp Setubal, Pathol, Setubal, Portugal
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
6260
引用
收藏
页码：I356 / I357
页数：2
相关论文
共 50 条
  • [21] Rare Biopsy Findings of IgA and C3 on Immunofluorescence in ANCA-Associated Vasculitis
    Habib, Nazia
    Khan, Muhammad Riaz
    Abid, Sidrah
    Faddoul, Geovani
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [22] Performance of Berden's Classification and ANCA Renal Risk Score for the Prediction of End-Stage Renal Disease in ANCA-associated Vasculitis
    Gercik, Onay
    Bilgin, Emre
    Solmaz, Dilek
    Cakalagaoglu, Fulya
    Saglam, Arzu
    Aybi, Ozge
    Kardas, Riza
    Soypacaci, Zeki
    Kabadayi, Gokhan
    Yildirim, Tolga
    Aysin, Idil Kurut
    Karadag, Omer
    Akar, Servet
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis
    Walsh, Michael
    Flossman, Oliver
    Berden, Annelies
    Westman, Kerstin
    Manns, Braden
    Jayne, David
    APMIS, 2009, 117 : 140 - 140
  • [24] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David R.
    Merkel, Peter A.
    Bekker, Pirow
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B1 - B1
  • [25] THE EFFECT OF AVACOPAN, A COMPLEMENT C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WITH RENAL DISEASE
    Jayne, David
    Merkel, Peter
    Bekker, Pirow
    McMahon, Jeffrey
    Schall, Thomas J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [26] Long-term outcome of kidney function in patients with ANCA-associated vasculitis
    Sachez-Alamo, Beatriz
    Moi, Laura
    Bajema, Ingeborg
    Berden, Annelies
    Flossmann, Oliver
    Hruskova, Zdenka
    Jayne, David
    Wester-Trejo, Maria
    Wallquist, Carin
    Westman, Kerstin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (09) : 1483 - 1493
  • [27] Effect of Avacopan, a Selective C5a Receptor Inhibitor, on Kidney Function in Patients with ANCA-Associated Vasculitis
    Jayne, David
    Merkel, Peter
    Bruchfeld, Annette
    Geetha, Duvuru
    Karras, Alexandre
    Niles, John
    Bekker, Pirow
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4117 - 4120
  • [28] ALLOGRAFT FAILURE IN KIDNEY TRANSPLANT RECIPIENTS WHOSE PRIMARY KIDNEY DISEASE WAS ANCA-ASSOCIATED VASCULITIS
    Kuhnel, L.
    Maizels, N.
    Hawley, C.
    Johnson, D.
    Gobe, G.
    Francis, R.
    Ellis, R.
    NEPHROLOGY, 2020, 25 : 37 - 37
  • [29] EVALUATION OF SERUM C3 LEVELS AND C3 IMMUNOFLUORESCENCE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: A RETROSPECTIVE COHORT STUDY
    Chalkia, Aglaia
    Thomas, Konstantinos
    Giannou, Panagiota
    Panagiotopoulos, Alexandros
    Hadziyannis, Emilia
    Kapota, Athanasia
    Gakiopoulou, Harikleia
    Vasilopoulos, Dimitrios
    Petras, Dimitrios
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [30] THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS
    Walsh, Michael
    Merkel, Peter
    Jayne, David
    RHEUMATOLOGY, 2019, 58
12345